Spots Global Cancer Trial Database for Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP
Official Title: Neoadjuvant Chemotherapy for Pancreatic Cancer; GS vs. GnP
Study ID: NCT05268692
Conditions
Study Description
Brief Summary: The effect of neoadjuvant chemotherapy for pancreatic cancer was gradually established. However it has been not clarified which regimen of neoadjuvant treatment for pancreatic cancer is the best.
Detailed Description: gemcitabine plus S-1 versus gemcitabine plus nab-paclitaxel
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Takehiro Okabayashi, Kochi, , Japan
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
